Research Admin Offices:

• HRS

Opportunity Type:

• Grant

Value:

Up to $750,000 US over three years

Disciplines:

• Health Sciences

Sponsors:

• Leukemia & Lymphoma Society

Deadlines:

Additional Dates:

• Sponsor LOI Due Date - October 16, 2025

Description:

This opportunity supports investigators developing novel approaches to the prevention, diagnosis, or treatment of hematologic malignancies and related premalignant conditions. It encourages conceptually innovative proposals grounded in molecular, cellular, or systems-level findings, with a clear pathway to clinical translation aimed at accelerating the application of basic research into patient care.

Resources:

Additional Details.

Contact:

If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.